Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2013 Oct 21;19(39):6590-7.
doi: 10.3748/wjg.v19.i39.6590.

Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass?

Marco Milone  1 , Matteo Nicola Dario Di Minno, Maddalena Leongito, Paola Maietta, Paolo Bianco, Caterina Taffuri, Dario Gaudioso, Roberta Lupoli, Silvia Savastano, Francesco Milone, Mario Musella
Affiliations
Comparative Study

Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass?

Marco Milone et al. World J Gastroenterol. .

Abstract

Aim: To investigate the weight loss and glycemic control status [blood glucose, hemoglobin A1c (HbA1c) and hypoglycaemic treatment].

Methods: The primary risk factor for type 2 diabetes is obesity, and 90% of all patients with type 2 diabetes are overweight or obese. Although a remarkable effect of bariatric surgery is the profound and durable resolution of type 2 diabetes clinical manifestations, little is known about the difference among various weight loss surgical procedures on diabetes remission. Data from patients referred during a 3-year period (from January 2009 to December 2011) to the University of Naples "Federico II" diagnosed with obesity and diabetes were retrieved from a prospective database. The patients were split into two groups according to the surgical intervention performed [sleeve gastrectomy (SG) and mini-gastric bypass (MGB)]. Weight loss and glycemic control status (blood glucose, HbA1c and hypoglycaemic treatment) were evaluated.

Results: A total of 53 subjects who underwent sleeve gastrectomy or mini-gastric bypass for obesity and diabetes were screened for the inclusion in this study. Of these, 4 subjects were excluded because of surgical complications, 7 subjects were omitted because young surgeons conducted the operations and 11 subjects were removed because of the lack of follow-up. Thirty-one obese patients were recruited for this study. A total of 15 subjects underwent SG (48.4%), and 16 underwent MGB (51.6%). After adjusting for various clinical and demographic characteristics in a multivariate logistic regression analysis, high hemoglobin A1c was determined to be a negative predictor of diabetes remission at 12 mo (OR = 0.366, 95%CI: 0.152-0.884). Using the same regression model, MGB showed a clear trend toward higher diabetes remission rates relative to SG (OR = 3.780, 95%CI: 0.961-14.872).

Conclusion: Although our results are encouraging regarding the effectiveness of mini-gastric bypass on diabetes remission, further studies are needed to provide definitive conclusions in selecting the ideal procedure for diabetes remission.

Keywords: Bariatric surgery; Bypass; Obesity and diabetes; Sleeve.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Changes in body mass index (A), glycemia (B) and hemoglobin A1c (C) values following surgery. HbA1c: Hemoglobin A1c; SG: Sleeve gastrectomy; MGB: Mini-gastric bypass; BMI: Body mass index.
Figure 2
Figure 2
Scatter plot of Pearson’s correlations between the percent change in glycemia and body mass index (A) and in hemoglobin A1c and body mass index (B) following surgical intervention. HbA1c: Hemoglobin A1c; BMI: Body mass index.
Figure 3
Figure 3
Prevalence of subjects achieving diabetes remission in the sleeve gastrectomy group and the mini-gastric bypass group. SG: Sleeve gastrectomy; MGB: Mini-gastric bypass.
See this image and copyright information in PMC

References

    1. Toghaw P, Matone A, Lenbury Y, De Gaetano A. Bariatric surgery and T2DM improvement mechanisms: a mathematical model. Theor Biol Med Model. 2012;9:16. - PMC - PubMed
    1. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arterioscler Thromb Vasc Biol. 2006;26:968–976. - PubMed
    1. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–591. - PubMed
    1. Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444:881–887. - PubMed
    1. Musella M, Milone M, Bellini M, Fernandez ME, Fernandez LM, Leongito M, Milone F. The potential role of intragastric balloon in the treatment of obese-related infertility: personal experience. Obes Surg. 2011;21:426–430. - PubMed

Publication types

MeSH terms